Vietnam Investment Review on MSN7d
Stimulating year ahead for pharma
Vietnam’s pharmaceutical market is expected to have a year of optimism after experiencing a multicoloured gamut in 2024.
"Trump might forget about Greenland. But also, he might not. Nobody knows. He operates on whims," @anneapplebaum writes.
The “magnificent seven” tech stocks have helped drive the U.S. stock market to record highs. Their soaring valuations imply elevated earnings for years to come. But on one measure of corporate ...
These diabetes and weight loss drugs work by slowing digestion and curbing ... In a statement sent to USA TODAY, a spokesperson for drug maker Novo Nordisk said the company welcomes any ...
More: Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations These diabetes and weight loss drugs work by slowing digestion and ... Drug companies Novo Nordisk and Eli Lilly ...
The highly anticipated Best Places to Work World Rankings for 2024 have ... fostering a forward-thinking and inclusive workplace. Novo Nordisk –A global healthcare company with over 95 ...
where Novo Nordisk, the maker of Ozempic and Wegovy is based.) These drugs have also been given partial credit for a recent dip in obesity rates in the US, which dropped in 2023 for the first time in ...
and to work with like-minded suppliers. One way to ensure that Novo Nordisk’s approach to sustainability is carried through all parts of the business has been the way it has approached educating ...
Turkey's growing power pollution a sign of things to come February 6, 2025 Novo Nordisk emissions grew 23 ... Norway's Hoegh maps out hydrogen delivery plans to Germany February 5, 2025 Norway's ...
Novo Nordisk's U.S.-listed shares rose 5% in intraday trading after the Ozempic and Wegovy maker's better-than-estimated ...
Danish pharmaceutical behemoth Novo Nordisk reported better-than-expected net profit in the fourth quarter, amid soaring ...